Evidence method
Level · gp.fundamentals.debt_to_revenue
158.04% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
ADMA · Jun 30, 2026
ADMA BIOLOGICS, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001140361-26-031445General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
1.81% · OPTIONAL · VALID
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
23.75% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
1.98% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
192.38% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
69.36% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
42.16% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
4.83% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
4.93% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History10 statesHistory building
Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/7 normalizedLevel 3Sep 30, 20240/7 normalizedLevel 3Dec 31, 20240/7 normalizedLevel 3Mar 31, 20250/8 normalizedLevel 3Jun 30, 20250/8 normalizedLevel 3Sep 30, 20250/9 normalizedLevel 3Dec 31, 20250/9 normalizedLevel 3Mar 31, 20267/9 normalizedLevel 3Jun 30, 20267/9 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 171.94%
- Current
- 158.04%
- Delta
- -13.91%
- Previous
- 2.22%
- Current
- 1.81%
- Delta
- -0.41%
- Previous
- 50.88%
- Current
- 23.75%
- Delta
- -27.13%
- Previous
- -0.27%
- Current
- 1.98%
- Delta
- 2.25%
- Previous
- 193.98%
- Current
- 192.38%
- Delta
- -1.60%
- Previous
- 70.53%
- Current
- 69.36%
- Delta
- -1.17%
- Previous
- 50.90%
- Current
- 42.16%
- Delta
- -8.74%
- Previous
- 2.27%
- Current
- 4.83%
- Delta
- 2.57%
- Previous
- 5.53%
- Current
- 4.93%
- Delta
- -0.60%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Biological Products, (No Diagnostic Substances) peers →Transitioned To · ADMA Fundamental State →Transitioned To · ADMA BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · ADMA CAPEX_INTENSITY_DECREASED →Transitioned To · ADMA CASH_GENERATION_DECREASED →Transitioned To · ADMA GROWTH_INCREASED →Transitioned To · ADMA INVENTORY_PRESSURE_DECREASED →Transitioned To · ADMA MARGIN_DECREASED →Transitioned To · ADMA PROFITABILITY_DECREASED →Transitioned To · ADMA R_AND_D_INTENSITY_INCREASED →Transitioned To · ADMA SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.